Abstract
Background Coarctation of the aorta (CoA) often leads to hypertension (HTN) post-treatment. Evidence is lacking for the current >20 mmHg peak-to-peak blood pressure gradient (BPGpp) guideline, which can cause aortic thickening, stiffening and dysfunction. This study sought to find the BPGpp severity and duration that avoid persistent dysfunction in a preclinical model, and test if predictors translate to HTN status in CoA patients.
Methods Rabbits (N=75; 5-12/group) were exposed to mild, intermediate or severe CoA (≤12, 13-19, ≥20 mmHg BPGpp) for ∼1, 3 or 22 weeks using dissolvable and permanent sutures with thickening, stiffening, contraction and endothelial function evaluated via multivariate regression. Relevance to CoA patients (N=239; age=0.01-46 years; median 3.7 months) was tested by retrospective review of predictors (pre-operative BPGpp, surgical age, etc.) vs follow-up HTN status.
Results CoA duration and severity were predictive of aortic remodeling and active dysfunction in rabbits, and HTN in CoA patients. Interaction between patient age and BPGpp at surgery contributed significantly to HTN, similar to rabbits, suggesting preclinical findings translate to patients. Machine learning decision tree analysis uncovered that pre-operative BPGpp and surgical age predict risk of HTN along with residual post-operative BPGpp.
Conclusions These findings suggest the current BPGpp threshold determined decades ago is likely too high to prevent adverse coarctation-induced aortic remodeling. The results and decision tree analysis provide a foundation for revising CoA treatment guidelines considering the interaction between CoA severity and duration to limit the risk of HTN.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The current study was partially supported by the American Heart Association under award number 15GRNT25700042 (JFL) as well as the National Institutes of Health - National Heart, Lung, and Blood Institute under award numbers R01HL142955 (JFL) and R15HL096096 (JFL). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the American Heart Association.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The current study was conducted after exempt determination by the Institutional Review Boards at the Medical College of Wisconsin and Shands Childrens Hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Text figures and tables updated to reflect latest version of the research study.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
3 Abbreviations and acronyms
- ACh
- Acetylcholine
- AUC
- Area under the receiver operative curve
- AUD
- Area under the dose response curve
- BMI
- body mass index
- BP
- Blood Pressure
- BPG
- Blood Pressure Gradient
- BPGpp
- Peak-to-peak blood pressure gradient
- BSA
- Body surface area
- BW
- Body weight
- CFPG
- continuous flow pressure gradient
- CoA
- Coarctation of the Aorta
- HTN
- Hypertension
- ICC
- intraclass correlation coefficient
- PE
- Phenylephrine
- SM
- Smooth muscle
